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The  rhizomes  of  Curcuma  caesia  Roxb. (zingiberacea)  are  traditionally  used  in treat-
ment  of  various  ailments  and metabolic  disorders  like  leukoderma,  asthma,  tumours,
piles,  bronchitis,  etc.  in  Indian  system  of  medicine.  Considering  the  importance  of
natural  products  in  modern  phytomedicine,  the  antioxidant  and  antimutagenic  activi-
ties of C.  caesia  Roxb.  rhizome  extract  and  its fractions  were  evaluated.  The  ethanolic
fraction  showed  highest  antioxidant  activity by  DPPH  assay  (86.91%)  comparable  to
ascorbic  acid  (94.77%)  with  IC50 value  of 418  g/ml  for  EECC  followed  by  MECC
(441.90  g/ml)  > EAECC(561  g/ml)  >  AECC(591  g/ml).  Based  on the antioxidant  activity,
three  of the  rhizome  extracts  were  evaluated  for their antimutagenic  properties  against
indirect  acting  mutagen  cyclophosphamide  (CP)  using  Salmonella  typhimurium  strains  TA98
and TA100.  The  antimutagenic  activity  of the  extracts  against  indirect  acting  mutagen
cyclophosphamide  in  the  presence  of  mammalian  metabolic  activation  system  was  found
to be  signiﬁcant  (p < 0.01,  p < 0.05).  All  the extracts  showed  similar  antimutagenicity  in dose
dependent  manner.  The  total  phenolic  content  as  well  as  reducing  ability  of  the  extracts
was  also determined.
© 2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).urcuma caesia Roxb.
ntioxidant activity
otal phenolic content
educing power
yclophosphamide
ntimutagenic activity. IntroductionThe emerging concepts of cancer is that the cancer
ells are unstable and its unstability is brought about
y the documentations of cascade of mutations caused
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icenses/by-nc-nd/4.0/).by mutagens and suggested that mutagenesis drives out
tumour progression [1]. Mutations results from the side
effects of free radicals such as hydrogen peroxides, super-
oxide anions, and organo peroxides, etc. produced by drugs,
ultraviolet radiations, ionising radiations, pollution as well
as the endproducts of normal metabolic process of aero-
bic organisms [2–4]. The interaction of the free radicals
with polyunsaturated fatty acids, nucleotides and disul-
phide bonds [5] has been implicated as the major factor
to cause the oxidation of the biological compounds and
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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eventually leads to mutations [6] and many degenarative
diseases like emphysema, cardiovascular, inﬂammatory
diseases, cataracts, etc. [5]. Cellular system has developed
many endogenous antioxidants such as superoxide dismu-
tase (SOD), catalase, glutathione, glutathione peroxidases
and reductase, and nonenzymatic antioxidants like vita-
min  E (tocopherols and tocotrienols), vitamin C, etc. [7]
to neutralise the free radicals [8]. This has triggered to
search for effective antioxidant agents from various sources
including plants. Many researchers have investigated that
the increase levels of antioxidants present in plants are
believed to decrease the oxidative damage and its harm-
ful effects [9]. Synthetic antioxidants such as butylated
hydroxytoluene (BHT), butylated hydroxyanisole (BHA)
are preferable but can cause serious ill effects in human
health as per recent reports Lobo et al. [10]. The use of
plants and medicinal plants has been recommended to
combat the effect of free radicals/mutagens because they
can induce phase II enzymes reducing the action of ini-
tiation, promotion or progression stages of cancer and
other degenerative diseases [11–14]. Also the plants are
rich source of secondary metabolites such as ﬂavonoids,
phenolics, carotenoids, coumarins, anthraquinones, tan-
nins, terpenoids, saponins that play a prominent role in
inhibiting human carcinogenesis and repair the cell muta-
tions [15].
Curcuma caesia Roxb. (black turmeric) is a perennial
herb with bluish black rhizomes and it is famous for its
medicinal properties. It is recognised as a medicinal herb to
possess with various properties such as anti-fungal activ-
ity Banerjee and Nigam [16], smooth muscle relaxant and
anti-asthmatic activity Arulmozhi et al. [17], bronchodilat-
ing activity Paliwal et al. [18], antioxidant activity Mangla
et al. [19], anxiolytic and CNS depressant activity, loco-
motor depressant, anti-convulsant Karmakar et al. [20],
anthelmintic activity Gill et al. [21], anti-bacterial activ-
ity Rajamma et al. [22], anti-ulcer activity Das et al. [23].
The phytochemical studies of C. caesia revealed the pres-
ence of multiple phytoconstituents like essential oils with
camphor, ar-turmerone, (Z) ocemene, ar-curcumene,1,8-
cineole, elemene, borneol, bornyl acetate, curcumene, etc.
[24]. To the best of our knowledge there is no report
available on the antimutagenic activity of C. caesia Roxb.
Therefore we  have selected the rhizome of this plant and
evaluated the antioxidant and antimutagenic activity of
some of the selected extracts against indirectly acting
mutagen cyclophosphamide.
2. Materials and methods
2.1. Plant material collection and extraction
Rhizomes of C. caesia Roxb. were collected in the month
of November 2012, from the region of Nambol, Bishnupur
District, Manipur, India. The rhizomes were cut into pieces
and sun dried. The dried rhizomes were coarsely powdered
and 100 g of it was successfully extracted with various sol-
vents starting from least polar solvents to more polar, i.e.
from petroleum ether to ethyl acetate, ethanol, methanol
and then ﬁnally to water through soxhlet at a temperature
of 50–60 ◦C for a period of 12–24 h. The crude extracts oforts 2 (2015) 423–428
each solvent were dried in water bath and kept for further
uses.
2.2. DPPH radical scavenging activity
The quenching of free radical activity of different
extracts were determined by spectrophotometric method
against 2,2-diphenyl-1-picryl hydrazyl (DPPH) follow-
ing [25]. 1 ml  of each extract of various concentrations
(25–800 g/ml) were mixed with 1 ml of DPPH (0.1 mM)
solution prepared in ethanol and incubated in dark for
20 min  and absorbance values were recorded at 517 nm.
1 ml  of ethanol and 1 ml  of ethanolic solution of DPPH
(0.2 mM)  was taken as control. Similarly 1 ml  of ethanolic
solution of ascorbic acid (200 g/ml) was  mixed with 1 ml
of DPPH ethanolic solution and absorbance values were
recorded. The radical scavenging activity was calculated
using the following formula:
DPPH radical scavenging activity (%) = Ab − Aa
Ab
× 100
where Ab is the absorption of the blank and Aa is the absorp-
tion of the extract sample.
2.3. Determination of total phenolic contents in the plant
extracts
The concentration of phenolics in plant extracts was
determined using Folin Ciocalteau method [26] with lit-
tle modiﬁcations. The extracts in the concentration of
1 mg/ml  was used in the analysis. The reaction mixture
was  prepared by mixing 0.5 ml  of each extract solution,
2.5 ml  of 10% Folin–Ciocalteu’s reagent dissolved in water
and 2.5 ml  of 7.5% NaHCO3. Blank was prepared, contain-
ing 0.5 ml ethanol, 2.5 ml  10% Folin–Ciocalteu’s reagent
dissolved in water and 2.5 ml  of 7.5% of NaHCO3. The sam-
ples were thereafter incubated at 45 ◦C for 45 min. The
absorbance were determined using spectrophotometer
at max = 765 nm.  The samples were prepared in tripli-
cate for each analysis and the mean value of absorbance
was  obtained. The same procedure was repeated for the
standard solution of gallic acid and the calibration line
was  constructed. Based on the measured absorbance, the
concentration of phenolics was  calculated from the cali-
bration line; then the content of phenolics in each extracts
was  expressed in terms of gallic acid equivalent (mg  of
GAE/100 g d.w. of extract).
2.4. Reducing power assay
The ability to reduce ferric ions to ferrous ions by the
antioxidants present in rhizomes of C. caesia Roxb. was
determined by the method of Oyaizu [27] with little mod-
iﬁcation. From the different concentrations of each extract
solutions (200–1000 g/ml), 1 ml  of each was mixed with
2.5 ml  of 0.2 M of phosphate buffer (pH = 6.6) and 2.5 ml
of 1% potassium ferricyanide. The mixture was  heated at
50 ◦C for 20 min  and then cooled followed by the addition
of 2.5 ml  of 10% TCA and then centrifuged at 3000 rpm for
10 min. 2.5 ml  of the supernatant was  again mixed with
2.5 ml  of distilled water and 0.5 ml  of 0.5% FeCl3 and the
logy Reports 2 (2015) 423–428 425
a
o
i
w
2
a
b
d
t
r
T
2
m
c
m
p
M
a
2
f
s
a
p
s
b
e
r
p
p
b
c
i
2
g
t
w
a
C
e
a
%
w
w
m
e
Fig. 1. DPPH method. EECC: ethanolic extract of Curcuma caesia Roxb.,
(EAECC) > 591 g/ml (AECC), the lowest being the highest
antioxidant activity. The ethanolic extract neutralised 50%
of free radicals at the concentration of 418 g/ml (Fig. 2).H.P. Devi et al. / Toxico
bsorbance was recorded at 700 nm against blank with-
ut extract. Increase in the absorbance values shows the
ncreasing reducing ability of the extracts. The entire test
as performed in triplicate.
.5. Bacterial strains
Salmonella typhimurium strains TA98 and TA100 which
re histidine-requiring mutants, were kindly provided
y IMTECH, Chandigarh, India and are maintained as
escribed by Maron and Ames [28]. The genotypes of
he test strains were checked routinely for their histidine
equirement, rfa mutatios, UV sensitivity (uvrB mutation).
hey were stored at −80 ◦C for further use.
.6. S9 preparation
S9 is the mitochondrial enzyme mix  required for
etabolic activation of indirect acting mutagens like
yclophosphamide. The S9 mixture was prepared from
ale rat liver using the chemicals 1 M glucose-6-
hosphate, 0.1 M NADP, 0.2 M phosphate buffer, 0.4 M
gCl2 + 1.65 M KCl (Himedia – India) as described by Maron
nd Ames [28]. S9 mix  was prepared fresh for each assay.
.7. Salmonella-microsome assay
The bacterial strains were incubated in Nutrient Broth
or 16 h at 37 ◦C in an orbital shaker to obtain a den-
ity of 2 × 109 colony forming units (CFU/ml). 0.1 ml  of
n overnight culture of bacteria and 0.5 ml  of sodium
hosphate buffer (0.2 M,  pH 7.4 for assay without S9)
upplemented with 0.2 mM l-histidine and 0.2 mM d-
iotin solution containing different concentrations of each
xtract. They were mixed using votexer for 10 min. The
esulting complete mixture was poured on minimal agar
lates prepared as described by Maron and Ames [28]. The
lates were incubated at 37 ◦C for 48 h and the revertant
acterial colonies of each plate were counted. Data were
ollected with a mean ± standard deviation of three exper-
ments (n = 3).
.8. Antimutagenicity testing
For the experiment with S9 mix, 0.1 ml  of overnight
rown bacterial cultures were taken followed by the addi-
ion of 0.2 mM.  Histidine-Biotin solution supplemented
ith each extracts at different concentrations, were mixed
nd incubated for 3 min. After incubation 0.1 ml  of the
P (500 g/plate) and 0.5 ml  of S9 mix  were added. The
xperiment was performed as mentioned above. Percent-
ge inhibition was calculated using the formula [29].
 Inhibition of mutagenicity = (R1 − SR)  − (R2 − SR)
R1 − SR × 100here R1 is the number of revertants without extracts but
ith CP, R2 the number of revertants with extracts plus
utagen and SR is the spontaneous revertants i.e. without
xtracts and mutagen.MECC: methanolic extract of Curcuma caesia Roxb., EaECC: ethyl acetate
extract of Curcuma caesia Roxb., AECC: aqueous extract of Curcuma caesia
Roxb.
2.9. Statistical analysis
The results are presented as the average and S.D.
(standard deviations) of three experiments with triplicate
plates/dose/experiment. The regression analysis was  car-
ried out in Microsoft Excel 2007 between % inhibition of
mutagenicity and values of concentrations of the plant
extracts. Student’s t test was  performed to compare the
mean values with the positive control.
3. Results
3.1. Antioxidant activity
The free radical scavenging activity of the rhizome
extracts of C. caesia Roxb. was  measured as decolorizing
activity following the trapping of the unpaired electron of
DPPH as shown in Fig. 1. The fractions showed a varied
free radical scavenging activity. The ethanol fraction was
found to be the most active free radical scavenger exhib-
ited (86.914% decrease at a concentration of 800 g/ml)
compared to ascorbic acid (94.770%). Likewise the crude
methanolic, ethyl acetate and aqueous extract showed
scavenging activity with a percent decrease of 83.104%,
70.44% and 69.19%. The IC50 value ranges in the order
of 418 g/ml (EECC) > 441.90 g/ml (MECC) > 561 g/mlFig. 2. Standard curve of gallic acid to ﬁnd out the total phenolic content.
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Table 1
Reducing power of the extracts.
Conc (g/ml) EECC MECC EaECC AECC
1000 2.480 ± 0.010 1.639 ± 0.029 0.899 ± 0.053 0.348 ± 0.023
800  2.277 ± 0.068 1.368 ± 0.029 0.468 ± 0.028 0.275 ± 0.015
500  1.511 ± 0.041 0.788 ± 0.005 0.333 ± 0.022 0.180 ± 0.009
200  0.775 ± 0.002 0.372 ± 0.001 0.159 ± 0.013 0.074 ± 0.002
Ascorbic acid (200 g/ml) 2.425 ± 0.03
Table 2
Number of his+ revertants in Salmonella typhimurium strains produced by Curcuma caesia Roxb. extracts against cyclophosphamide.
Treatment conc. (g/ml) TA98 TA100
−S9 +S9 −S9 +S9
S.R 92.66 ± 6.94 304 ± 23 55 ± 4.54 213 ± 13.06
P.C:  50 299.66 ± 26.44 718 ± 94 135.66 ± 19.36 652.66 ± 71.2
EECC:  50 116.33 ± 18.14 395.11 ± 71.2* 98 ± 10.42 398.66 ± 64.8*
500 111.33 ± 19.14 386.51 ± 74* 80.33 ± 10.63 379.33 ± 63.8*
5000 104.33 ± 21.14 341.45 ± 93.72* 71 ± 16.63 334.66 ± 86.51*
MECC: 50 179.66 ± 39.98 491.67 ± 98.28* 126.66 ± 3.39 434.33 ± 44.93*
500 163.66 ± 47.6 487.66 ± 56* 105.66 ± 5.39 412.33 ± 43.4*
5000 144.66 ± 13.55 401.66 ± 93.14* 91.66 ± 10.17 385.33 ± 74*
ECC: 50 221.66 ± 15.9 596.67 131.33 ± 3.86 466.33 ± 21.7*
500 211.33 ± 22.89 562.67 ± 3.5** 121 ± 5.54 449.66 ± 45.7*
5000 95.66 ± 31.56 479.66 ± 33.15* 97.66 ± 9.74 410.66 ± 51.8*
The data represented in the table is the mean ± S.D. values of three replicates.
* p < 0.01.
ct of Cu** p < 0.05.
EECC: ethanolic extract of Curcuma caesia Roxb.; MECC: methanolic extra
positive control; C.P: cyclophosphamide; S.R: spontaneous revertants.
3.2. Total phenolic content
The total phenolic contents in the examined plant
extracts using the Folin Cioclteu’s reagent is expressed
in terms of gallic acid equivalent (the standard curve:
y = 0.0178x + 0.148; R2 = 0.9831). Total phenolic contents in
the examined extracts ranged from MECC = 52.11 mg/100 g
d.w., EECC = 68.64 mg/100 g d.w., EaECC = 38 mg/100 g d.w.,
AECC = 4.82 mg/100 g d.w. of the extract. The highest con-
centration of phenols was measured in ethanolic followed
by methanolic, ethyl acetate and aqueous extracts.
The reducing power of C. caesia Roxb. rhizome extracts
was dose dependent and is presented in the following
table. The maximum absorbance of ethanolic extracts at
1000 g/ml is more or near to ascorbic acid at 200 g/ml as
given in Table 1. Reducing power methods indirectly eval-
uates the antioxidant activity (Qureshi et al. [51]) (Table 2).
The increase in the absorbance indicates an increase in
reductive ability [30].
Based on the promising antioxidant and reducing activ-
ity, ethanolic, methanolic and aqueous extracts were
evaluated for their antimutagenic activity by Ames test
against indirect acting mutagen cyclophosphamide. All the
extracts were found to inhibit in dose dependent manner.
Linear relationship between extract dose and antimuta-
genic response in the case of EECC without S9 is strong
in the strain TA98 (r2 = 0.99) followed by TA100 (r2 = 0.97),
with S9 it is strong in the strain TA98 (r2 = 0.99) followed by
TA100 (r2 = 0.95). At all the doses antimutagenic response
was signiﬁcant at (p < 0.01) against both the strains with
a percent mutagenicity decrease from 77.99 to 90.95 forrcuma caesia Roxb.; AECC: aqueous extract of Curcuma caesia Roxb.; P.C:
TA98 followed by TA100 with percent antimutagenicity
starting from 57.77 to 72.32. Similar trend was  followed
for methanoilc extract of C. caesia Roxb. Linear relation-
ship between extract dose and antimutagenic response in
the case of MECC without S9 is strong in the strain TA98
(r2 = 0.99) followed by TA100 (r2 = 0.97), with S9 it is strong
in the strain TA98 (r2 = 0.99) followed by TA100 (r2 = 0.86).
At all the doses antimutagenic response was  signiﬁcant
at (p < 0.01) with the percent mutagenicity decrease from
54.66 to 76.41 in case of TA98 followed by TA100 with
the percent mutagenicity decrease from 49.65 to 60.80 in
MECC. The signiﬁcant level shown was (p < 0.01) for all
concentrations 50 g, 500 g and 5000 g. Linear relation-
ship between extract dose and antimutagenic response
in the case of AECC without S9 is strong in the strain
TA98 (r2 = 0.98) followed by TA100 (r2 = 0.95), with S9 it
is same for both the strain TA98 (r2 = 0.95) and TA100
(r2 = 0.95). At the dose of 50 g of AECC antimutagenic
response was insigniﬁcant with percent inhibition of 29.30
but at 500 g the antimutagenic response was  signiﬁcant
at (p < 0.05) with percent inhibition of 37.51 and at the
dose 5000 g it was signiﬁcant at (p < 0.01) (57.57% inhi-
bition) in case of TA98 and in case of TA100 in AECC the
signiﬁcant level shown was (p < 0.01) for all concentra-
tions with the percent mutagenicity decrease from 29.30
to 57.57.4. Discussion
Considerable attention has been focussed in recent
years on the exploration of phytotherapeutic agents for
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he treatment of oxidative stress and mutation related
isorders. The use of medicinal plants is perhaps the old-
st method of coping with illness. They can be easily
etabolised inside the body without any harmful effects
hat leads to the phytochemical based remedies [31–34].
eactive oxygen intermediates like superoxides, hydro-
en peroxides and hydroxyl radicals are known to mediate
acromolecular damages by reacting with nucleic acids,
roteins as well as various membrane components thus act
s direct and indirect initiators of mutagenesis and carcino-
enesis [35]. On the basis of this it has been hypothesised
hat the involvement of antioxidant might be considered as
he safest approach in the prevention of process leading to
utagenesis. The chemistry of free radicals is complicated
nd it caused a major limitation in the identiﬁcation of free
adical scavenging activity. To withstand this problem the
otential antioxidant substance are tested in in vitro model
nd such approaches expand the scope of antioxidant activ-
ty. The mechanism that contributes to the antioxidant
apacity of phenols and ﬂavanoids include free radical
cavenging ability, hydrogen or electron donation abil-
ty, chelation of redox active metals ions, modulation of
ene expression and interaction with the cell signalling
athways [36]. Therefore, we have examined the rhizome
xtracts of C. caesia Roxb. for antioxidant activity by DPPH
ree radical scavenging assay, total phenolic content and
educing power assay. The use of DPPH assay provides an
asy and a rapid way to evaluate antioxidants by spec-
rophotometer [37]. The purple colour of DPPH reduces
o light yellow with the intervention of plant extract; the
ost probable mechanism of action was hydrogen dona-
ion by the extracts [38]. Out of the four different extracts
f rhizome DPPH radical scavenging activities follows in
he order of EECC > MECC > EaECC > AECC with their per-
entage of inhibition ranging from −15.27 to 86.91%. In
act, the tested extracts are the complex mixtures of several
ompounds, particularly phenolic compounds which have
iverse chemical structures that determine various prop-
rties. Rich source of phenolics are of increasing interest
owadays because they retard the oxidative degradation
f bio molecules [39]. The chemical structure of phenolic
ompound which has hydroxyl group attached to ben-
ene ring in its structure provides them the ability to
ct as free radical scavenger [40]. When reactive oxygen
pecies are present at a certain concentration the bond
etween O and H is broken. The released hydrogen ion is
ade available to nucleophilic radicals which subsequently
uenched their free radicals [42]. The phenol content of
he C. caesia Roxb. extracts was found to be 52.11 mg/GAE
or MECC, 68.64 mg/GAE for EECC, 38 mg/GAE for EaECC
nd 4.82 mg/gGAE for AECC in 100 g of dry weight of
he extract in the present study. Literature reviews of
arangthem and Haokip [41] also conﬁrms that maximum
urcuminoids, oil content, ﬂavonoids, phenolics, different
mportant amino acids, protein and high alkaloids are con-
ained in the rhizome of this species. Antioxidants have
een reported to act as scavengers of singlet oxygen and
ree radicals in biological systems [42,43]. As stated by
yaizu [27], plant extracts has the reducing ability to trans-
orm Fe3+ to Fe+2 and reductones are responsible for it
44]. They have been found to exert antioxidant activityorts 2 (2015) 423–428 427
by breaking the free radical chains by donating a hydro-
gen atom [45]. The reducing power of extracts of C. caesia
Roxb. was  found to be remarkable and each extract was
found to rise as the concentration gradually increases.
The reducing power of the extracts follows the order
EECC > MECC > EaECC > AECC as shown in the table as well
as in the graph.
The antioxidant properties of phytochemicals are linked
to their ability to scavenge free radicals generated either
endogenously or by exogenous agents. These preventive
agents can inhibit the mutation and cancer initiation pro-
cess by modulating phase I and phase II enzymes, by
blocking reactive species either by scavenging, electron
donation or through chelation and thus maintains the DNA
structure. The inhibition of mutagenesis are grouped into
two namely desmutagens and bioantimutagens. It has been
hypothesised that bioantimutagens act as second stage
inhibitors that blocks the mutagen before they could attack
the DNA [46] and bioantimutagenic effect of phytochem-
icals is determined in co incubation method [47]. The
different extracts of C. caesia Roxb. have shown the follow-
ing order of antimutagenicity EECC > MECC > AECC; against
indirect acting mutagen cyclophosphamide (500 g/plate).
The results were based on the number of induced revertant
colonies detected. According to Ames et al. [48], a com-
pound is classiﬁed as a mutagen if it is able to increase at
least twice the number of revertants as compared to spon-
taneous revertants. Earlier Morfﬁ et al. [49] have reported
the antimutagenic activity of Magnifera indica against CP
in the strain TA100. Higher mutagenicity was  found when
CP was  activated with S9 but inhibition of this microsomal
activity was  observed in the presence of rhizome extract.
The present results showed the antimutagenic activity in
Ames test that may  be attributed in part to powerful rad-
ical scavenger associated with the extract. According to
Negi et al. [50], a compound is found to possess its less
antimutagenic activity if its percentage of inhibition is less
than 25%, a moderate activity if the percentage inhibition
value lies between 25% and 40% and a strong antimuta-
genicity effect if it is more than 40%. Ethanolic extract
reduces the mutagenicity caused by indirect acting muta-
gen cyclophosphamide by 97.21% and 90.30% respectively
in the strains TA98 and TA100 (in the presence of S9) at the
highest tested dose (5000 g/plate) which shows strong
antimutagenic activity. From the results it was found that
all the extracts showed strong effective antimutagenicity
against cyclophosphamide.
5. Conclusion
In conclusion, the present study has shown for the ﬁrst
time that C. caesia Roxb. rhizome extract is a promising
source for its antimutagenic compounds. Further studies
are needed to isolate the active principles present in it.
The present work supported the increasing evidence that
the rhizome extract of C. caesia Roxb. plays an important
role in cancer chemoprevention, particularly in defending
cells from DNA damage induced by oxidative mutagens and
by inhibiting CYP enzymes as documented in the present
study.
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